Oxurion

Oxurion Interest Coverage

The Interest Coverage Ratio of Oxurion (OXUR.BR) as of Oct 15, 2026 is 8.68. In the previous year, Interest Coverage Ratio was -2.44 — a change of -455.40% (higher).

Interest Coverage

8.68

YoY

-455.40%

Last updated:

Interest Coverage Ratio of Oxurion is 2024 8.68 . Interest Coverage Ratio of Oxurion was 2023 -2.44 . It decreases by -455.40% higher compared to the previous year.

The Oxurion Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
37.05 EUR
Jan 1, 2018
-80.08 EUR
Jan 1, 2019
-306.81 EUR
Jan 1, 2020
-303.14 EUR
Jan 1, 2021
-72.21 EUR
Jan 1, 2022
-2.98 EUR
Jan 1, 2023
-2.44 EUR
Jan 1, 2024
8.68 EUR
The Oxurion Interest Coverage history
YEARInterest CoverageYoY
8.68-455.40%
-2.44-17.90%
-2.98-95.88%
-72.21-76.18%
-303.14-1.20%
-306.81+283.11%
-80.08-316.16%
37.05-150.63%
-73.18+96.69%
-37.21+27.08%
-29.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oxurion Stock analysis

What does Oxurion do? Oxurion NV is a biotechnology company based in Heverlee, Belgium, operating within the healthcare sector. The company has 77 employees and went public on July 7, 2006. Oxurion focuses on developing and commercializing treatments for vitreoretinal diseases. Its lead product, JETREA (ocriplasmin), received U.S. Food and Drug Administration approval for the treatment of symptomatic vitreomacular adhesion (VMA) and was launched in January 2013. The company collaborates with Alcon, a division of Novartis, for the commercialization of JETREA outside the United States. In Europe, JETREA is approved for the treatment of vitreomacular traction (VMT), including cases associated with macular holes of 400 microns or smaller, with launches in the United Kingdom and Germany. Oxurion is also researching anti-PIGF (Placental Growth Factor), known as TB-403, for potential use in ophthalmic and oncology treatments. The company maintains operations in Belgium, the United States, and Ireland, with its headquarters in Heverlee, Vlaams-Brabant. Oxurion's website is www.oxurion.com. Oxurion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oxurion stock

Interest Coverage Ratio of Oxurion is 8.68 in 2024.

Interest Coverage Ratio of Oxurion changed from -2.44 to 8.68, representing a -455.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Oxurion since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Oxurion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Oxurion

All Key Metrics — Oxurion